UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
(Mark One)
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended September 30, 2015
or
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period from _________ to _________
Commission file number: 000-55473
BIOSIG TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
|
Delaware
|
|
26-4333375
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
8441 Wayzata Blvd, Suite 240
Minneapolis, MN 55426
(Address of principal executive offices) (zip code)
(763) 999-7331
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer o
|
Accelerated filer o
|
|
Non-accelerated filer o
|
Smaller reporting company x
|
|
(Do not check if a smaller reporting company)
|
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
As of November 13, 2015, there were 15,488,033 shares of registrant’s common stock outstanding.
We are filing this Amendment No. 1 (this "Amendment") to our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2015, originally filed with the Securities and Exchange Commission (the "SEC") on November 13, 2015 (the "Original Filing"), solely for the purpose of correcting a typographical error on the header page. An incorrect box was checked that corresponds to whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. We are also including with this Amendment the complete text of Item 6 of the Original Filing as amended.
This Amendment is limited in scope to the portions of the Original Filing discussed above and does not amend, update or change any other items or disclosures contained in the Original Filing. This Amendment continues to speak as of the date of the Original Filing and we have not updated the disclosures contained therein to reflect any events that occurred at any subsequent date.
|
31.01
|
|
| |
|
|
31.02
|
|
| |
|
|
32.01
|
|
| |
|
|
101 INS*
|
XBRL Instance Document
|
| |
|
|
101 SCH*
|
XBRL Taxonomy Extension Schema Document
|
| |
|
|
101 CAL*
|
XBRL Taxonomy Calculation Linkbase Document
|
|
101 LAB*
|
XBRL Taxonomy Labels Linkbase Document
|
| |
|
|
101 PRE*
|
XBRL Taxonomy Presentation Linkbase Document
|
| |
|
|
101 DEF*
|
XBRL Taxonomy Extension Definition Linkbase Document
|
*Exhibits were previously filed with the BioSig Technologies Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2015, filed with the Securities and Exchange Commission on November 13, 2015.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| |
BIOSIG TECHNOLOGIES, INC.
|
| |
|
|
|
Date: November 17, 2015
|
By:
|
/s/ GREGORY D. CASH
|
|
| |
|
Gregory D. Cash
|
| |
|
Chief Executive Officer (Principal Executive Officer)
|
| |
|
|
| |
|
|
|
Date: November 17, 2015
|
By:
|
/s/ STEVEN CHAUSSY
|
|
| |
|
Steven Chaussy
|
| |
|
Chief Financial Officer (Principal Financial Officer
|
| |
|
and Principal Accounting Officer)
|